Displaying 1 - 1 of 1
| Active Ingredient | GRISEOFULVIN |
| Therapeutic Class | ANTIFUNGALS, MISCELLANEOUS |
| Indications | Severe tinea infections. Not effective against candida albicans. |
| Caution | Headache, gastrointestinal upset, rash, dry mouth, photosensitivity. Affects warfarin metabolism. Avoid in pregnancy, liver failure. |
| Dose Range | Adult: 500mg-1g daily as a single dose or in divided doses (1g is for difficult to treat fungal infections) after meals for 30 days or more. Pediatric: 5-10mg/kg daily in 2 divided doses or as a single dose after meals. The oral suspension is reserved f |
| Drug Interactions | |
| Pregnancy | Griseofulvin studies have shown the drug to be embryotoxic and/or teratogenic in More ... |
| Breast Feeding | Avoid use unless potential benefit outweighs risk. |